T1	PROC 855 891	consentimiento informado por escrito
#1	AnnotatorNotes T1	C0811741; Obtain informed written consent; Health Care Activity
T2	CHEM 135 150	antirretroviral
#2	AnnotatorNotes T2	C0599685; Anti-Retroviral Agents; Pharmacologic Substance
T3	PROC 129 150	pauta antirretroviral
#3	AnnotatorNotes T3	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T4	CHEM 151 160	efavirenz
#4	AnnotatorNotes T4	C0674428; efavirenz; Organic Chemical · Pharmacologic Substance
T5	CHEM 161 170	tenofovir
#5	AnnotatorNotes T5	C0384228; tenofovir; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T6	CHEM 171 184	emtricitabina
#6	AnnotatorNotes T6	C0909839; emtricitabine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T7	DISO 208 227	infección por HIV-1
T8	DISO 281 300	Infección por VIH-1
#7	AnnotatorNotes T8	C2363741; HIV-1 infection; Disease or Syndrome
T9	CHEM 341 348	ATRIPLA
#8	AnnotatorNotes T9	C1724016; Atripla; Organic Chemical · Pharmacologic Substance
T10	DISO 1126 1136	mutaciones
#9	AnnotatorNotes T10	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
T11	PROC 441 450	detección
#10	AnnotatorNotes T11	C1511790; Detection; Therapeutic or Preventive Procedure
T12	PROC 501 504	CD4
#11	AnnotatorNotes T12	C0243009; CD4+ Lymphocyte Count; Laboratory Procedure
T13	ANAT 396 406	plasmática
#12	AnnotatorNotes T13	C0032105; Plasma; Body Substance
T14	PROC 579 597	Prueba de embarazo
#13	AnnotatorNotes T14	C0032976; Pregnancy Tests; Diagnostic Procedure
T15	PROC 657 680	métodos anticonceptivos
#14	AnnotatorNotes T15	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T16	CHEM 792 799	fármaco
#15	AnnotatorNotes T16	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T17	PROC 977 986	protocolo
#16	AnnotatorNotes T17	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T18	PROC 1088 1109	pauta antirretroviral
#17	AnnotatorNotes T18	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T19	CHEM 1094 1109	antirretroviral
#18	AnnotatorNotes T19	C0599685; Anti-Retroviral Agents; Pharmacologic Substance
T20	CHEM 1154 1163	efavirenz
#19	AnnotatorNotes T20	C0674428; efavirenz; Organic Chemical · Pharmacologic Substance
T21	CHEM 1165 1174	tenofovir
#20	AnnotatorNotes T21	C0384228; tenofovir; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T22	CHEM 1177 1190	emtricitabina
#21	AnnotatorNotes T22	C0909839; emtricitabine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T23	PROC 1216 1235	tratamiento crónico
#22	AnnotatorNotes T23	C0023977; Long-term care; Health Care Activity (?)
T24	CHEM 1246 1253	ATRIPLA
#23	AnnotatorNotes T24	C1724016; Atripla; Organic Chemical · Pharmacologic Substance
T25	CHEM 1377 1388	medicamento
#24	AnnotatorNotes T25	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T26	DISO 1531 1554	Enfermedad psiquiátrica
#25	AnnotatorNotes T26	C0004936; Mental disorders; Mental or Behavioral Dysfunction
T27	DISO 1595 1600	signo
#26	AnnotatorNotes T27	C0311392; Physical findings; Finding
T28	DISO 1611 1622	alcoholismo
#27	AnnotatorNotes T28	C0001973; Alcoholic Intoxication, Chronic; Mental or Behavioral Dysfunction
T29	DISO 1628 1651	consumo de otras drogas
T30	PROC 325 336	tratamiento
#28	AnnotatorNotes T30	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T31	PROC 384 406	Carga viral plasmática
T32	Date 13 17	2012
T33	LIVB 257 264	Adultos
#29	AnnotatorNotes T33	C0001675; Adult; Age Group
T34	Age 266 274	≥18 años
T35	Duration 358 378	los últimos dos años
T36	Duration 459 486	al menos los 2 últimos años
T37	Neg_cue 598 606	negativa
T38	LIVB 610 632	mujeres en edad fértil
#30	AnnotatorNotes T38	C4324275; Woman of childbearing potential; Population Group
T39	Age 621 632	edad fértil
T41	Duration 698 716	al menos 2 semanas
T42	Date 727 732	día 1
T43	Duration 746 760	mínimo 6 meses
T44	CONC 775 787	última dosis
T45	LIVB 821 830	pacientes
#31	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	LIVB 912 924	investigador
#32	AnnotatorNotes T46	C0035173; Research Personnel; Professional or Occupational Group
T47	LIVB 1017 1026	Pacientes
#33	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	Duration 1228 1235	crónico
#34	AnnotatorNotes T48	C0205191; chronic; Temporal Concept
T49	Duration 1281 1292	los 6 meses
T50	LIVB 1318 1326	paciente
#35	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T52	LIVB 1518 1526	paciente
#36	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T54	Date 1601 1607	actual
T55	LIVB 390 395	viral
#37	AnnotatorNotes T55	C0042776; Virus; Virus
T56	PHYS 589 597	embarazo
#38	AnnotatorNotes T56	C0032961; Pregnancy; Organism Function
T57	PROC 103 121	reducción de dosis
#39	AnnotatorNotes T57	C2348004; Agent Dose Decreased; Therapeutic or Preventive Procedure
T58	LIVB 222 227	HIV-1
#40	AnnotatorNotes T58	C0019704; HIV-1; Virus
T59	LIVB 295 300	VIH-1
#41	AnnotatorNotes T59	C0019704; HIV-1; Virus
T40	LIVB 1499 1505	médico
#42	AnnotatorNotes T40	C0031831; Physicians; Professional or Occupational Group
T51	CHEM 1645 1651	drogas
#43	AnnotatorNotes T51	C0086190; Illicit Drugs; Hazardous or Poisonous Substance
T53	PROC 965 972	visitas
#44	AnnotatorNotes T53	C1512346; Patient Visit; Health Care Activity
A1	Assertion T56 Negated
A2	Population_data T38 Age
A3	Status T10 History_of
A4	Assertion T25 Contraindicated
A5	Status T26 History_of
#45	AnnotatorNotes T7	C2363741; HIV-1 infection; Disease or Syndrome
#46	AnnotatorNotes T54	C0521116; Current (present time); Temporal Concept 
T60	Quantifier_or_Qualifier 1571 1581	controlada
A6	Assertion T60 Negated
T61	Neg_cue 1568 1570	no
T62	Neg_cue 1428 1430	no
T63	Observation 1451 1481	adherencia correcta al estudio
A7	Assertion T63 Negated
T64	Observation 1414 1423	condición
#47	AnnotatorNotes T64	C4745084; Medical Condition; Finding
T65	Observation 302 321	estabilidad clínica
#48	AnnotatorNotes T65	C1282982; Patient's condition stable; Finding
R1	Causes Arg1:T59 Arg2:T8	
R2	Used_for Arg1:T9 Arg2:T30	
R3	Has_Duration_or_Interval Arg1:T9 Arg2:T35	
R4	Location_of Arg1:T13 Arg2:T31	
T66	Result_or_Value 416 450	por debajo del límite de detección
R5	Overlap Arg1:T31 Arg2:T36	
R6	Has_Result_or_Value Arg1:T31 Arg2:T66	
R7	Overlap Arg1:T8 Arg2:T65	
R8	Causes Arg1:T58 Arg2:T7	
R9	Used_for Arg1:T2 Arg2:T3	
R10	Combined_with Arg1:T4 Arg2:T5	
R11	Combined_with Arg1:T5 Arg2:T6	
R12	Used_for Arg1:T4 Arg2:T57	
R13	Used_for Arg1:T2 Arg2:T57	
R14	Has_Age Arg1:T33 Arg2:T34	
T67	Result_or_Value 505 523	superior a 350/mm3
R15	Has_Result_or_Value Arg1:T12 Arg2:T67	
T68	CONC 530 573	momento de la consideración para el estudio
R16	Overlap Arg1:T12 Arg2:T68	
R17	Negation Arg1:T37 Arg2:T56	
R18	Experiences Arg1:T38 Arg2:T14	
R19	Experiences Arg1:T38 Arg2:T56	
R20	Has_Age Arg1:T38 Arg2:T39	
R21	Experiences Arg1:T38 Arg2:T15	
T69	Quantifier_or_Qualifier 681 691	aceptables
#49	AnnotatorNotes T69	C1879533; Acceptable; Qualitative Concept 
R22	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T69	
R23	Has_Duration_or_Interval Arg1:T15 Arg2:T41	
R24	Before Arg1:T15 Arg2:T42	
R25	After Arg1:T15 Arg2:T43	
R26	After Arg1:T15 Arg2:T44	
R27	Has_Dose_or_Strength Arg1:T16 Arg2:T44	
R28	Experiences Arg1:T38 Arg2:T16	
T70	Observation 930 972	capaces de seguir el diseño de las visitas
T71	Observation 1048 1066	fracaso virológico
A8	Status T71 History_of
R29	Experiences Arg1:T47 Arg2:T71	
R30	Overlap Arg1:T71 Arg2:T18	
R31	Used_for Arg1:T19 Arg2:T18	
R32	Overlap Arg1:T23 Arg2:T24	
R33	Has_Duration_or_Interval Arg1:T23 Arg2:T48	
R34	Overlap Arg1:T23 Arg2:T49	
T72	PROC 1333 1340	estudio
#50	AnnotatorNotes T72	C0008976; Clinical Trials; Research Activity
R35	Before Arg1:T23 Arg2:T72	
R36	Experiences Arg1:T50 Arg2:T23	
R37	Experiences Arg1:T50 Arg2:T24	
R38	Negation Arg1:T62 Arg2:T63	
R39	Before Arg1:T64 Arg2:T63	
R40	Experiences Arg1:T52 Arg2:T64	
R41	Negation Arg1:T61 Arg2:T60	
R42	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T60	
R43	Overlap Arg1:T27 Arg2:T54	
R44	Overlap Arg1:T28 Arg2:T54	
R45	Overlap Arg1:T29 Arg2:T51	
#51	AnnotatorNotes T29	C0242510; Drug usage; Mental or Behavioral Dysfunction (?)
R46	Causes Arg1:T28 Arg2:T27	
R47	Causes Arg1:T29 Arg2:T27	
R48	Overlap Arg1:T29 Arg2:T54	
R49	Overlap Arg1:T51 Arg2:T54	
R50	Used_for Arg1:T4 Arg2:T3	
#52	AnnotatorNotes T31	C3835525; HIV-1 RNA viral load in plasma by target amplification; Laboratory Procedure (?)
#53	AnnotatorNotes T71	C1699206; Virologic failure; Finding
#54	AnnotatorNotes R27	(?)
#55	AnnotatorNotes T44	C1762893; Date last dose; Temporal Concept
A9	Experiencer T40 Other
A10	Experiencer T52 Patient
A11	Experiencer T33 Patient
A12	Experiencer T38 Patient
A13	Experiencer T45 Patient
A14	Experiencer T46 Other
A15	Experiencer T47 Patient
A16	Experiencer T50 Patient
T73	Result_or_Value 598 606	negativa
R51	Has_Result_or_Value Arg1:T14 Arg2:T73	
